Eye Health / Ophthalmology Drugs
Prescription drugs and medicines for eye conditions and eye diseases. Studies in this area include: cataracts, eye infections, glaucoma, macular degeneration, near-sighted corrective surgery, and others.
The list of FDA approved drugs for ophthalmology appears below. Click any link to view the full drug information.
Treatment for postoperative inflammation in patients who have undergone cataract extraction
Treatment for post-surgical inflammation following cataract extraction
For the treatment of pain and inflammation following cataract surgery.
Over-the-counter combination vasoconstrictor/antihistamine product for opthalmic use
For anesthesia during ophthalmologic procedures
pemirolast potassium ophthalmic solution
Treatment for open-angle glaucoma and ocular hypertension
Treatment for seasonal allergic conjunctivitis
For the treatment of seasonal and perennial allergic rhinitis
For the treatment of bacterial conjunctivitis
For the treatment of itching associated with allergic conjunctivitis
For the treatment of bacterial conjunctivitis
For lowering IOP in patients with chronic open-angle glaucoma or ocular hypertension
Treatment during ocular surgical procedures
Treatment for glaucoma or ocular hypertension
For the treatment of corneal cystine crystal accumulation due to cystinosis
For the treatment of inflammation and pain associated with ocular surgery
For the treatment of neovascular (wet) age-related macular degeneration
Treatment for post-operative eye inflammation
For the treatment of diabetic macular edema
For the treatment of neovascular (wet) age related macular degeneration
For the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
For the treatment of wet age-related macular degeneration.
Treatment for corneal ulcers
Over-the-counter antihistamine eye drop
For the treatment of macular edema following branch retinal vein occlusion or central retinal vein occlusion
For treatment of bacterial conjunctivitis
For the treatment of open-angle glaucoma or ocular hypertension
For the treatment of low tear production.
Treatment for Sjogren's Syndrome
For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
For the treatment of cytomegalovirus retinitis in patients with AIDS
Treatment for inflammation of the cornea in children due to herpes simplex virus
Treatment for cytomegalovirus (CMV) retinitis
For the treatment of wet age-related macular degeneration (wet AMD)
Drug delivery system for the treatment of cytomegalovirus
Treatment for CMV in AIDS patients
Treatment for the prevention of itching of the eye
For the treatment of elevated intraocular pressure
For the treatment of acute herpetic keratitis
For the treatment of bacterial conjunctivitis
FDA Approved Eye Health / Ophthalmology Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA eye health / ophthalmology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The eye health / ophthalmology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
